Results for this period
First quarter1 April 2026 to 30 June 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
In the Chemicals Business, strong sales of products for the electronics industry, due to increased AI-related demand and other factors, higher domestic sales volumes, and higher selling prices accompanying the surge in nonferrous metal prices contributed to higher revenue. These gains were partly offset by increased research and development expenses and raw material costs, as well as lower revenue from contract processing. In the Building Materials Business, a rebound from temporarily reduced demand, the development of new customers, and expanded sales of new products contributed to higher revenue and profit.
No applicable matters.
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2026 to 30 June 2026 |
| Net Sales | ¥7,463 million (YoY +16.6%) |
| Operating profit | ¥863 million (YoY -1.6%) |
| Ordinary income | ¥1,129 million (YoY +5.8%) |
| Profit attributable to owners of the parent | ¥740 million (YoY -6.6%) |
| Net income per share | ¥38.01 |
| Equity ratio | End of the current fiscal period 82.4 / End of previous period 82.4 |
| Total assets | ¥63,180 million |
| Net assets | ¥52,040 million |
| Full-year earnings forecast | Net Sales ¥28,640 million (YoY +2.2%) / Operating profit ¥1,310 million (YoY -61.5%) / Ordinary income ¥1,800 million (YoY -52.9%) / Net income ¥1,250 million (YoY -45.2%) |
| Annual Dividend Forecast | ¥90 → ¥90（0.0%） |
| Segment revenue | Pharmaceuticals business ¥6,393,328 thousand (YoY +17.1%), Building Materials Business ¥1,070,641 thousand (YoY +14.1%) |
| Segment profit | Pharmaceuticals business ¥902,166 thousand (YoY -8.3%), Building Materials Business ¥204,139 thousand (YoY +50.2%) |
| Regional sales | Domestic Pharmaceuticals business ¥5,219,783 thousand / Building Materials Business ¥1,070,641 thousand / Total ¥6,290,424 thousand / Overseas expansion Pharmaceuticals business ¥1,173,544 thousand / Building Materials Business ¥0 thousand / Total ¥1,173,544 thousand |
| Depreciation and amortization | ¥415,690 thousand |
| Impairment loss | No applicable matters. |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of non-current assets ¥461 thousand, Gain on sale of investment securities － / Extraordinary loss Loss on Disposal of Fixed Assets ¥2,698 thousand, Early retirement-related expenses ¥148,559 thousand |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New Number of companies — companies / Company name Not disclosed / Excluded Number of companies — companies / Company name Not disclosed |
| Material subsequent events | No applicable matters. |
| Availability of Supplementary Financial Results Materials | No |
| Availability of Financial Results Briefing | Whether applicable No / Subject person Not disclosed |
| Issued Shares at Period-End | 20,280,000 Shares |
| Treasury Shares at Period-End | 782,886 Shares |
| Factors Behind Changes in Business Performance | In the Chemicals Business, strong sales of products for the electronics industry, due to increased AI-related demand and other factors, higher domestic sales volumes, and higher selling prices accompanying the surge in nonferrous metal prices contributed to higher revenue. These gains were partly offset by increased research and development expenses and raw material costs, as well as lower revenue from contract processing. In the Building Materials Business, a rebound from temporarily reduced demand, the development of new customers, and expanded sales of new products contributed to higher revenue and profit. |
Items this document does not state (9)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Net sales increased because sales expanded in both the Chemicals Business and the Building Materials Business. Operating income declined due to higher selling, general and administrative expenses and other factors, while net income attributable to owners of the parent declined mainly because early-retirement-related expenses of ¥148 million were recorded as an extraordinary loss.